Synthesis and pharmacological properties of new derivatives of 4-methyl-5-oxalo-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin -2-one and β-oxo-5-(4-methyl-1H-2,3,4,5-tetrahydro -1,5-benzodiazepin-2-one)propionic acid

Acta Poloniae Pharmaceutica - Drug Research

Volumn 53, Issue 6, 1996, Pages 425-430

  Nawrocka, Wanda ^a   Rutkowska, Maria ^a   Szela̧g, Adam ^a   Barczyńska, Jadwiga ^a   Kȩdzierska Goździk, Lidia ^a   Błaszczyk, Feliks ^a   Dziwiszek, Wojciech ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

1,5 benzodiazepin 2 ones; Pharmacological investigations; Synthesis

Indexed keywords

4 METHYL 5 OXALO 1H 2,3,4,5 TETRAHYDRO 1,5 BENZODIAZEPIN 2 ONE; BENZODIAZEPINE DERIVATIVE; BETA OXO 5 (4 METHYL 1H 2,3,4,5 TETRAHYDRO 1,5 BENZODIAZEPIN 2 ONE)PROPIONIC ACID; BUTANOL; PENTANOL; PROPANOL; PSYCHOTROPIC AGENT; RESERPINE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ARTICLE; CHEMICAL STRUCTURE; DRUG SYNTHESIS; ESTERIFICATION; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINONES; CENTRAL NERVOUS SYSTEM; DRUG EVALUATION, PRECLINICAL; FEMALE; LETHAL DOSE 50; MALE; MICE; RATS; RATS, WISTAR;

EID: 0030448565     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nawojski A., Nawrocka W., WIlimowski M., Orzechowska-Juzwenko K., Barczyńska J., Kȩdzierska L., Wojewódzki W., Przybylska B., Felsztyńska J.: Pol. J.Pharmacol. Pharm. 31, 515 (1979).
2. Nawojski A., Nawrocka W., Liszkiewicz H.: Pol. J. Pharmacol. Pharm. 34, 423 (1982).
3. Nawojski A., Nawrocka W., Liszkiewicz H.: Pol. J. Pharmacol. Pharm. 34, 429 (1982).
4. Nawojski A., Nawrocka W., Liszkiewicz H.: Pol. J. Pharmacol. Pharm. 35, 531 (1983).
5. Nawojski A., Nawrocka W., Liszkiewicz H., Krzywosiński L., Bogdal M.: Pol. J. Pharmacol. Pharm. 40, 191 (1988).
6. Nawrocka W., Liszkiewicz H., Nawojski A., Wilimowski M., Kȩdzierska-Goździk L., Barczyńska J., Wojewódzki W., Duś E., Szela̧ig A., Rutkowska M.: Pol. J. Pharmacol. Pharm. 43, 495 (1991).
7. Aron C., Simon P., Larousse C., Boissier J.R.: Neuropharmacology 10, 459 (1971).
8. Corne S.J., Pickering R.W., Warner B.T.: Br. J. Pharmacol. 20, 106 (1963).
9. Costall B., Domeney A.M., Gerrard P.A., Kelly M.E., Naylor R.J.: J. Pharm. Pharmacol. 40, 302 (1988).
10. Costall B., Naylor R.J.: Life Sci. 11, 1135 (1972).
11. Delini-Stula A., Morpurgo C.: Int. J. Neuropharmacol. 7, 391 (1968).
12. Litchfield J.T., Wilcoxon F.: J. Pharmacol. Exper. Ther. 96, 99 (1949).
13. Porsolt R.D., Bertin A., Jalfre M.: Arch. Int. Pharmacodyn. Ther. 229, 327 (1977).
14. Tedeschi D.H., Tedeschi R.E., Fellows E.J.: J. Pharmacol. Exp. Ther. 126, 223 (1959).
15. Toman J.E.P., Swinyard S.A., Goodman L.S.: J. Neurophysiol. 9, 231 (1946).